[Federal Register Volume 66, Number 168 (Wednesday, August 29, 2001)]
[Notices]
[Pages 45685-45686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-21772]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial

[[Page 45686]]

property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Review and Analysis of Tobacco Industry Documents.
    Date: September 14, 2001.
    Time: 8:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn, 5520 Wisconsin Ave, Chevy Chase, MD 20815.
    Contact Person: Gerald G. Lovinger, PhD., Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6116 Executive Boulevard, Room 8101, Rockville, MD 20892-
7405, 301/496-7987.

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.


(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 21, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-21772 Filed 8-28-01; 8:45 am]
BILLING CODE 4140-01-M